The sleep apnea implants market size is estimated to be valued at US$ 317.1 million in 2023 and is expected to reach US$ 1,158.1 million by 2033. The adoption of Sleep Apnea Implants is likely to advance at a CAGR of 13.8% during the forecast period.
The rising prevalence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a severe sleep disorder that may increase the risk of fatal accidents or other health-related complications caused due to disturbed sleep has necessitated innovation in Sleep Apnea Implants. Consequences of sleepiness and sleep deprivation are common among people who are shift workers and have headed to several sleep-related disorders. Problems such as OSA, insomnia, jet lag narcolepsy, and sleepwalking are a few of the sleep-related disorders which remain undiagnosed. For instance, according to a study published in the National Institutes of Health journal, around 30% of the adult American population suffers from insomnia and 10% from chronic
A large pool of the population affected by sleep apnea has become more awareness about these disorders and other related ailments. The increasing prevalence of sleep disorders has led to expansion in hospitals and other care centers in various areas, with the establishment of separate divisions dealing with sleep disorders. These sleep centers have increased awareness on tracking sleep patterns for better sleep. Sleep-related awareness is consistently contributing to the increase in the diagnosis rate of sleep disorders. This is expected to drive the sleep apnea implants market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for sleep apnea implants. The report tracks the global sales of sleep apnea implants in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and sleep apnea implants in particular.
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | US$ 317.1 million |
| Projected Market Size (2033) | US$ 1,158.1 million |
| CAGR through (2023 to 2033) | 13.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
OSA is a progressive disorder affecting more than 200 million people worldwide. According to a study in Lancet, 936 million (95% CI 903–970) adults aged 30–69 years (men and women) were suffering from mild to severe OSA globally. The highest number of affected cases was found in China, followed by the USA, Brazil, and India in 2019.
According to FMI’s analysis, sales of sleep apnea implants have grown at a 12.1% CAGR between 2018 and 2022. Sleep apnea implants have become a potential tool improving airflow and reducing sleep apnea in patients suffering from a sleep disorder. Hypoglossal neurostimulation devices have gained popularity based on their efficacy as compared to other products. FMI expects the global sleep apnea implants market to grow at a 13.8% CAGR through 2033.
| Period | Market Size (in US$ million) |
|---|---|
| 2017 | US$ 42.6 million |
| 2022 | US$ 247.2 million |
| 2022 | US$ 317.1 million |
| 2033 | US$ 1,1158.1 million |
Unlocking the Dream: Exploring Lucrative Opportunities in the Sleep Apnea Implants Market
Manufacturers are actively focusing on research and development to innovate advanced devices that meet the customers’ demand and are likely to gain popularity with high revenue share in the competitive market. Advancements in sleep apnea devices include sleep trackers that track sleep patterns based on movement monitoring and also monitor the heart rate. For example, many companies are developing wearables that go on your wrist or finger while sleeping and collect data about the movement and heart rate, while some also track breathing patterns.
Developing countries, such as China and India, have a relatively large population base and the incidence of sleep-related disorders such as insomnia and sleep apnea is comparatively higher than that in other countries. Sleep-related disorders are a serious issue in China and India, which is an opportunity for the leading manufacturers to expand their business in the region and increase their market share. Thus, the rising prevalence of sleep-related disorders is expected to offer robust opportunities for the manufacturers in the sleep apnea implants market.
Nurturing a Silent Revolution: Government and Non-governmental Initiatives Powering Sleep Apnea Implants Sales
Numerous government and non-government organizations such as Circadian Sleep Disorders Network and the American Sleep Apnea Association (ASAA) conduct sleep awareness programs regarding the importance of ample sleep and usage of sleep apnea devices. These organizations are launching several awareness programs to educate people about sleep hygiene and technological aid to get better sleep. For example, Sleep Awareness Week was celebrated by the National Sleep Foundation with the theme “Begin with Sleep Moreover” in March 2018.
Various organizations are improving their services to offer greater customer satisfaction. For instance, the American Sleep Association is an organization dedicated to improving public health by increasing awareness about the importance of sleep and the dangers of sleep disorders. Government approval is expected to propel the sleep apnea implants market growth.
Due to an increase in the need for assessment of OSA breathe in peripheral artery disease and limb ischemia, many manufacturers seek 510(k) Premarket Notification from the U.S. Food and Drug Administration (“FDA”) which demonstrates the device to be safe and effective, equivalent to a legally marketed device. For example, in May 2019, Siesta Medical, Inc. (Private) announced FDA clearance for expanded indications for its Encore™ Tongue Suspension System for the treatment of obstructive sleep apnea.
Implementing government guidelines for prescription reformation attracts end-users, which is expected to boost the demand for sleep apnea implants. For instance, in February 2021, the FDA authorized the marketing of eXciteOSA® (Signifier Medical Technologies), a new prescription intended to reduce sleep snoring and OSA in patients 18 years and older.
Unmasking the Barriers: Unlocking the Potential of Sleep Apnea Implants amidst Sales Impediments
Continuous positive airway pressure (CPAP) is the most popular technology adopted for the assessment of sleep deprivation-associated disorders. CPAP devices come in different price ranges depending upon the number of features. The high upfront cost can have a negative impact on the end users’ decision to purchase sleep apnea implants.
Some of the most effective sleep disorder treatments are quite expensive. As a general rule, the surgery associated with the placement of the Inspire hypoglossal nerve stimulator may cost $30,000 to $40,000 (with the device itself costing about $20,000 of this total). Thus, high cost of the technology as well as the treatment is the major factor expected to hamper the market growth.
Unleashing the Potential: Unraveling the Vast Opportunity Landscape in the United States Sleep Apnea Implants Market
The healthcare system of the United States is highly renowned for its well-developed infrastructure and high expenditure. The care regimes in the care centers and hospitals are covered by regulatory rules and insurance policies. The massive hospital bills incurred other than Medicare escalate the market in the country.
The United States government and regulatory bodies are actively adopting several cost-containment plans to reduce their healthcare burden. The shift from a volume-based to a value-based system is majorly driven by the various measures undertaken by providers, governments, biotechnology companies, and insurance payers. Some of the measures are outcome-based profits, pricing, risk-sharing, competitive tendering, and price control.
A value-based healthcare system will not only provide improved outcomes through integrated care pathways, but also levy pricing pressure on medical device companies, and this is likely to impact investments in the R&D of advanced medical treatment technologies. In June 2020, the IDE trial was approved by FDA, with the first United States and international implants.
Due to the high prevalence of sleep disorders in the United States, the government as well as non-government organizations are conducting campaigns to raise general awareness among people suffering from these diseases. This is likely to support the overall market growth in the country.
Breaking New Ground: Unleashing Innovation's Power for Success in the German Medical Device Market
The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. The health expenditure was expected to surge to 407.4 billion euros by 2019, presenting a lucrative landscape for the expansion of sleep apnea implants sales.
The presence of domestic players such as Carl Martin GmbH is supporting the expansion in Germany. The company has been investing significantly in expansion efforts.
Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population, are covered by statutory health insurance. Another 11% of the population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive growth opportunities.
Unleashing the Dragon's Purchasing Power: China's Soaring Disposable Income Set to Fuel Market Surge
Increasing disposable income can have a significant impact on the development of the economy in emerging countries, which results in the affordability of proper healthcare treatments. China’s per capita disposable income reached about 4,961 U.S. dollars in 2020, more than double that in 2010.
The potential for high healthcare insurance and rising disposable income will contribute to increasing affordability of healthcare services and also accessibility to expensive equipment for the treatment of diseases. The market in China is expected to witness significant growth at a CAGR of around 15.7% during the forecast period.
Navigating the Slumbering Challenges: Unveiling the Restraints Encountered by GCC Countries in the Sleep Apnea Implants Domain
Lack of awareness about complete sleep and related disorders and lack of treatment or low adoption of therapy due to high cost raises the prevalence of sleep disorders in GCC Countries. Due to limited campaigning and assessment of the undiagnosed disorders, there seems to occur less usage of these devices in hospitals in GCC Countries.
Poor healthcare facilities in some countries restrain the growth of the sleep apnea implants market. Due to financial burdens, governments fail to provide proper treatment and are unable to facilitate campaigns to create awareness among the population, which may impact the usage of advanced devices. The market in GCC Countries is expected to witness sluggish growth during the forecast period.
Principal Consultant
OSA Dominance Unveiled: Unraveling the Sleep Apnea Implants Market Share Phenomenon
The OSA segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold 91.34% of the market share, in terms of indication, by the end of 2033.
OSA is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep. The rising prevalence of OSA across the global population leads to a spike in share for the OSA segment in the market.
Unlocking a Breath of Relief: The Phenomenon behind Hypoglossal Neurostimulation Devices' Reign in the Sleep Apnea Implants Market
Hypoglossal Neurostimulation Devices hold the highest share in the sleep apnea implants market. Hypoglossal neurostimulation devices are meant to treat pharyngeal tone and stimulates genioglossus protrusion to the open airway by the tongue during sleep.
These devices reduce the risk for severe dysphagia and throat pain that witnessed by a surge in the demand for the device in the market.
Pioneering Partnerships: Unveiling the Powerful Influence of Hospitals on Sleep Apnea Implants Sales
The hospital segment is expected to dominate the sleep apnea implants market through the forecast period. Higher footfall of sleep apnea patients in hospitals will seal their position as the dominant end user.
In the ever-evolving realm of sleep apnea implants, a fierce competition unfolds as key players vie for supremacy. Industry frontrunners deploy innovative technologies, cutting-edge research, and strategic partnerships to gain a decisive edge. Titans clash as they strive to capture significant market shares, revolutionize treatment outcomes, and improve patient experiences.
Established giants showcase their prowess, while nimble startups disrupt the status quo with disruptive solutions. As the battle intensifies, companies tirelessly invest in R&D, focusing on implant efficacy, patient comfort, and remote monitoring capabilities. In this dynamic arena, the competitive landscape continuously evolves, forging new alliances, sparking acquisitions, and fueling innovation. Amidst this fierce contest, it is the sleep apnea sufferers who stand to benefit the most, as a relentless pursuit of excellence drives the industry towards a brighter future.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Strategies for Sleep Apnea Implants Manufacturers to Expand in the Market
Product Portfolio:
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 317.1 million |
| Market Value in 2033 | US$ 1,158.1 million |
| Growth Rate | CAGR of 13.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available upon Request |
The market is set to amount to US$ 1,158.1 million by 2033.
The growth potential of the market is 13.8% through 2033.
Manufacturers are developing advanced devices to popularize their brands and gain a larger share.
American Sleep Apnea Association (ASAA) and Circadian Sleep Disorders Network are contributing to the product demand.
Developments in neurostimulation technology have a prominent influence on the market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Phrenic Nerve Stimulator
5.3.2. Hypoglossal Neurostimulation Devices
5.3.3. Bone Screw Implant System
5.3.4. Flexible Tongue Retractor System
5.3.5. Palatal Implants/Pillar Procedure
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033
6.3.1. Central Sleep Apnea
6.3.2. Obstructive Sleep Apnea (OSA)
6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Office Based Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Indication
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Indication
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Indication
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Indication
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Indication
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Indication
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product
12.2.3. By Indication
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Indication
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Indication
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Indication
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product
14.2.3. By Indication
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Indication
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Indication
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Indication
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Indication
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Indication
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Indication
16.5.2.3. By End User
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Indication
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Indication
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Indication
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Indication
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Indication
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Indication
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Indication
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Indication
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Indication
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Indication
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Indication
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Indication
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Indication
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Indication
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Indication
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Indication
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Inspire Medical Systems
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Respicardia, Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Medtronic Plc
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. LinguaFlex LLC
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Siesta Medical, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Avery biomedical
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Nyxoah SA
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. LivaNova/ImThera
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. ASAHI KASEI CORP
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. SomnoMed
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Sleep Apnea Implants Market
